A Phase 2, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy
Phase of Trial: Phase II
Latest Information Update: 17 May 2018
At a glance
- Drugs Metformin; S 707106
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 18 Apr 2012 Planned End Date changed from 1 Feb 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 13 Sep 2011 Additional location (Puerto Rico) identified as reported by ClinicalTrials.gov.